DC has updated several MERS-CoV evaluation and lab specimen recommendations: 1) the incubation period has been extended to 14 days; 2) the clinical presentation may not initially include respiratory symptoms; 3) co-morbid conditions and immunosuppression may increase risk for infection and/or severe disease; and 4) lower respiratory tract specimens are the highest priority specimens to… Read More »
MERS-CoV
CDC Health Update (HAN)
CDC Health Update on MERS-CoV
Updated guidance from CDC states that: 1) testing for MERS-CoV and other respiratory pathogens can be done simultaneously; 2) positive results for another respiratory pathogen should not preclude testing for MERS-CoV; and 3) clusters of patients with severe, unexplained respiratory illness should be considered for MERS-CoV testing. Read the full text of the August 12,… Read More »
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Interim Recommendations for Evaluation, Infection Control, & Laboratory Submission (updated on 5/20/14)
As of June 12, 2014, the CDC has updated its Interim Guidance for testing for MERS-CoV. Testing criteria have been liberalized for individuals who have been in a healthcare facility in or near the Arabian Peninsula in which healthcare-associated MERS cases have been identified. Click here to learn more about updated testing guidance. Please contact… Read More »